Effects of brain-derived neurotrophic factor on dopaminergic function and motor behavior during aging

Genes, Brain and Behavior

Volumn 10, Issue 2, 2011, Pages 186-198

  Boger, H A ^a   Mannangatti, P ^a   Samuvel, D J ^a   Saylor, A J ^a   Bender, T S ^a   McGinty, J F ^a   Fortress, A M ^a   Zaman, V ^a   Huang, P ^b   Middaugh, L D ^a   Randall, P K ^a   Jayanthi, L D ^a   Rohrer, B ^a   Helke, K L ^a   Granholm, A C ^a   Ramamoorthy, S ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aging; BDNF; Dopamine; Mice; Striatum; Uptake

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE; DOPAMINE TRANSPORTER; VESICULAR MONOAMINE TRANSPORTER 2;

AGE; AGING; ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; BODY WEIGHT; CONTROLLED STUDY; GENOTYPE; LOCOMOTION; MALE; MOTOR ACTIVITY; MOTOR PERFORMANCE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION;

AGING; ANIMALS; BODY WEIGHT; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CORPUS STRIATUM; DOPAMINE; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SPACE; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICRODIALYSIS; MOTOR ACTIVITY; POSTURAL BALANCE; POTASSIUM; SUBSTANTIA NIGRA; SYNAPTIC VESICLES; SYNAPTOSOMES; VESICULAR MONOAMINE TRANSPORT PROTEINS;

MUS;

EID: 79951776031     PISSN: 16011848     EISSN: 1601183X     Source Type: Journal    
DOI: 10.1111/j.1601-183X.2010.00654.x     Document Type: Article

References (81)

1. Abidin, I., Kohler, T., Weiler, E., Zoidl, G., Eysel, U.T., Lessmann, V. & Mittmann, T. (2006) Reduced presynaptic efficiency of excitatory synaptic transmission impairs LTP in the visual cortex of BDNF-heterozygous mice. Eur J Neurosci 24, 3519-3531.
2. Albeck, D., Mesches, M.H., Juthberg, S., Browning, M., Bickford, P.C., Rose, G.M. & Granholm, A.C. (2003) Exogenous NGF restores endogenous NGF distribution in the brain of the cognitively impaired aged rat. Brain Res 967, 306-310.
3. Archer, J. (1975) Rodent sex differences in emotional and related behavior. Behav Biol 14, 451-479.
4. Baker, S.A., Stanford, L.E., Brown, R.E. & Hagg, T. (2005) Maturation but not survival of dopaminergic nigrostriatal neurons is affected in developing and aging BDNF-deficient mice. Brain Res 1039, 177-188.
5. Barbeau, A. (1973) Aging and the extrapyramidal system. J Am Geriatr Soc 21, 145-149.
6. Bartoletti, A., Cancedda, L., Reid, S.W., Tessarollo, L., Porciatti, V., Pizzorusso, T. & Maffei, L. (2002) Heterozygous knock-out mice for brain-derived neurotrophic factor show a pathway-specific impairment of long-term potentiation but normal critical period for monocular deprivation. J Neurosci 22, 10072-10077.
7. Benmansour, S., Deltheil, T., Piotrowski, J., Nicolas, L., Reperant, C., Gardier, A.M., Frazer, A. & David, D.J. (2008) Influence of brain-derived neurotrophic factor (BDNF) on serotonin neurotransmission in the hippocampus of adult rodents. Eur J Pharmacol 587, 90-98.
8. Bennett, D.A., Beckett, L.A., Murray, A.M., Shannon, K.M., Goetz, C.G., Pilgrim, D.M. & Evans, D.A. (1996) Prevalence of parkinsonian signs and associated mortality in a community population of older people. N Engl J Med 334, 71-76.
9. Bennett, J.L., Zeiler, S.R. & Jones, K.R. (1999) Patterned expression of BDNF and NT-3 in the retina and anterior segment of the developing mammalian eye. Invest Ophthalmol Vis Sci 40, 2996-3005.
10. Bickford, P., Heron, C., Young, D.A., Gerhardt, G.A. & De La Garza, R. (1992) Impaired acquisition of novel locomotor tasks in aged and norepinephrine-depleted F344 rats. Neurobiol Aging 13, 475-481.
11. Boger, H.A., Middaugh, L.D., Huang, P., Zaman, V., Smith, A.C., Hoffer, B.J., Tomac, A.C. & Granholm, A.C. (2006) A partial GDNF depletion leads to earlier age-related deterioration of motor function and tyrosine hydroxylase expression in the substantia nigra. Exp Neurol 202, 336-347.
12. Busch, A.E., Quester, S., Ulzheimer, J.C., Gorboulev, V., Akhoundova, A., Waldegger, S., Lang, F. & Koepsell, H. (1996) Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1. FEBS Lett 395, 153-156.
13. Canals, J.M., Pineda, J.R., Torres-Peraza, J.F., Bosch, M., Martin-Ibanez, R., Munoz, M.T., Mengod, G., Ernfors, P. & Alberch, J. (2004) Brain-derived neurotrophic factor regulates the onset and severity of motor dysfunction associated with enkephalinergic neuronal degeneration in Huntington's disease. J Neurosci 24, 7727-7739.
14. Caro, J.F., Sinha, M.K., Kolaczynski, J.W., Zhang, P.L. & Considine, R.V. (1996) Leptin: the tale of an obesity gene. Diabetes 45, 1455-1462.
15. Carola, V., D'Olimpio, F., Brunamonti, E., Mangia, F. & Renzi, P. (2002) Evaluation of the elevated plus-maze and open-field tests for the assessment of anxiety-related behaviour in inbred mice. Behav Brain Res 134, 49-57.
16. Cass, W.A., Harned, M.E. & Bailey, S.L. (2002) Enhanced effects of 6-hydroxydopamine on evoked overflow of striatal dopamine in aged rats. Brain Res 938, 29-37.
17. Chemuturi, N.V. & Donovan, M.D. (2007) Role of organic cation transporters in dopamine uptake across olfactory and nasal respiratory tissues. Mol Pharm 4, 936-942.
18. Chourbaji, S., Hellweg, R., Brandis, D., Zorner, B., Zacher, C., Lang, U.E., Henn, F.A., Hortnagl, H. & Gass, P. (2004) Mice with reduced brain-derived neurotrophic factor expression show decreased choline acetyltransferase activity, but regular brain monoamine levels and unaltered emotional behavior. Brain Res Mol Brain Res 121, 28-36.
19. Crusio, W.E., Goldowitz, D., Holmes, A. & Wolfer, D. (2009) Standards for the publication of mouse mutant studies. Genes Brain Behav 8, 1-4.
20. Cruz-Muros, I., Afonso-Oramas, D., Abreu, P., Rodriguez, M., Gonzalez, M.C. & Gonzalez-Hernandez, T. (2008) Deglycosylation and subcellular redistribution of VMAT2 in the mesostriatal system during normal aging. Neurobiol Aging 29, 1702-1711.
21. Daws, L.C., Munn, J.L., Valdez, M.F., Frosto-Burke, T. & Hensler, J.G. (2007) Serotonin transporter function, but not expression, is dependent on brain-derived neurotrophic factor (BDNF): in vivo studies in BDNF-deficient mice. J Neurochem 101, 641-651.
22. DeFelice, L.J. & Goswami, T. (2007) Transporters as channels. Annu Rev Physiol 69, 87-112.
23. Dejesus, O.T., Endres, C.J., Shelton, S.E., Nickles, R.J. & Holden, J.E. (2001) Noninvasive assessment of aromatic L-amino acid decarboxylase activity in aging rhesus monkey brain in vivo. Synapse 39, 58-63.
24. Depino, A.M. & Gross, C. (2007) Simultaneous assessment of autonomic function and anxiety-related behavior in BALB/c and C57BL/6 mice. Behav Brain Res 177, 254-260.
25. Disshon, K.A. & Dluzen, D.E. (1997) Estrogen as a neuromodulator of MPTP-induced neurotoxicity: effects upon striatal dopamine release. Brain Res 764, 9-16.
26. Dluzen, D.E., Anderson, L.I., McDermott, J.L., Kucera, J. & Walro, J.M. (2002) Striatal dopamine output is compromised within +/- BDNF mice. Synapse 43, 112-117.
27. Dluzen, D.E., Gao, X., Story, G.M., Anderson, L.I., Kucera, J. & Walro, J.M. (2001) Evaluation of nigrostriatal dopaminergic function in adult +/+ and +/- BDNF mutant mice. Exp Neurol 170, 121-128.
28. Dluzen, D.E., McDermott, J.L., Anderson, L.I., Kucera, J., Joyce, J.N., Osredkar, T. & Walro, J.M. (2004) Age-related changes in nigrostriatal dopaminergic function are accentuated in +/- brain-derived neurotrophic factor mice. Neuroscience 128, 201-208.
29. Dluzen, D.E., Story, G.M., Xu, K., Kucera, J. & Walro, J.M. (1999) Alterations in nigrostriatal dopaminergic function within BDNF mutant mice. Exp Neurol 160, 500-507.
30. Do, T., Kerr, B. & Kuzhikandathil, E.V. (2007) Brain-derived neurotrophic factor regulates the expression of D1 dopamine receptors. J Neurochem 100, 416-428.
31. Nature Neuroscience Editorial. (2009) Troublesome variability in mouse studies. Nat Neurosci 12, 1075.
32. Ernfors, P., Kucera, J., Lee, K.F., Loring, J. & Jaenisch, R. (1995) Studies on the physiological role of brain-derived neurotrophic factor and neurotrophin-3 in knockout mice. Int J Dev Biol 39, 799-807.
33. Ernfors, P., Lee, K.F. & Jaenisch, R. (1994) Mice lacking brain-derived neurotrophic factor develop with sensory deficits. Nature 368, 147-150.
34. Fernandes, C., Gonzalez, M.I., Wilson, C.A. & File, S.E. (1999) Factor analysis shows that female rat behaviour is characterized primarily by activity, male rats are driven by sex and anxiety. Pharmacol Biochem Behav 64, 731-738.
35. Finn, J.P. III, Merickel, A. & Edwards, R.H. (1998) Analysis of neurotransmitter transport into secretory vesicles. Methods Enzymol 296, 144-162.
36. Franklin, K. & Paxinos, G. (2001) The Mouse Brain in Stereotaxic Coordinates, Academic Press, New York.
37. Friedman, J.M. (1997) Leptin, leptin receptors and the control of body weight. Eur J Med Res 2, 7-13.
38. Granholm, A.C., Mott, J.L., Bowenkamp, K., Eken, S., Henry, S., Hoffer, B.J., Lapchak, P.A., Palmer, M.R., van Horne, C. & Gerhardt, G.A. (1997) Glial cell line-derived neurotrophic factor improves survival of ventral mesencephalic grafts to the 6-hydroxydopamine lesioned striatum. Exp Brain Res 116, 29-38.
39. Griebel, G., Belzung, C., Perrault, G. & Sanger, D.J. (2000) Differences in anxiety-related behaviours and in sensitivity to diazepam in inbred and outbred strains of mice. Psychopharmacology (Berl) 148, 164-170.
40. Guiard, B.P., David, D.J., Deltheil, T., Chenu, F., Le Maitre, E., Renoir, T., Leroux-Nicollet, I., Sokoloff, P., Lanfumey, L., Hamon, M., Andrews, A.M., Hen, R. & Gardier, A.M. (2008) Brain-derived neurotrophic factor-deficient mice exhibit a hippocampal hyperserotonergic phenotype. Int J Neuropsychopharmacol 11, 79-92.
41. Halberda, J.P., Middaugh, L.D., Gard, B.E. & Jackson, B.P. (1997) DAD1- and DAD2-like agonist effects on motor activity of C57 mice: differences compared to rats. Synapse 26, 81-92.
42. Hebert, M.A. & Gerhardt, G.A. (1997) Behavioral and neurochemical effects of intranigral administration of glial cell line-derived neurotrophic factor on aged Fischer 344 rats. J Pharmacol Exp Ther 282, 760-768.
43. Hebert, M.A. & Gerhardt, G.A. (1998) Normal and drug-induced locomotor behavior in aging: comparison to evoked DA release and tissue content in fischer 344 rats. Brain Res 797, 42-54.
44. Hebert, M.A. & Gerhardt, G.A. (1999) Age-related changes in the capacity, rate, and modulation of dopamine uptake within the striatum and nucleus accumbens of Fischer 344 rats: an in vivo electrochemical study. J Pharmacol Exp Ther 288, 879-887.
45. Himi, T., Cao, M. & Mori, N. (1995) Reduced expression of the molecular markers of dopaminergic neuronal atrophy in the aging rat brain. J Gerontol A Biol Sci Med Sci 50, B193-B200.
46. Ingram, D.K. (2000) Age-related decline in physical activity: generalization to nonhumans. Med Sci Sports Exerc 32, 1623-1629.
47. Jaber, M., Dumartin, B., Sagne, C., Haycock, J.W., Roubert, C., Giros, B., Bloch, B. & Caron, M.G. (1999) Differential regulation of tyrosine hydroxylase in the basal ganglia of mice lacking the dopamine transporter. Eur J Neurosci 11, 3499-3511.
48. Jayanthi, L.D., Samuvel, D.J., Buck, E.R., Reith, M.E. & Ramamoorthy, S. (2007) Regulation of Biogenic Amine Transporters. In Abel Lajtha Editor, r.e., 2007 (ed), Handbook of Neurochemistry and Molecular Neurobiology. Springer-Verlag press, pp. 363-386.
49. Jones, S.R., Gainetdinov, R.R., Jaber, M., Giros, B., Wightman, R.M. & Caron, M.G. (1998) Profound neuronal plasticity in response to inactivation of the dopamine transporter. Proc Natl Acad Sci U S A 95, 4029-4034.
50. Joyce, J.N., Renish, L., Osredkar, T., Walro, J.M., Kucera, J. & Dluzen, D.E. (2004) Methamphetamine-induced loss of striatal dopamine innervation in BDNF heterozygote mice does not further reduce D3 receptor concentrations. Synapse 52, 11-19.
51. Katoh-Semba, R., Semba, R., Takeuchi, I.K. & Kato, K. (1998) Age-related changes in levels of brain-derived neurotrophic factor in selected brain regions of rats, normal mice and senescence-accelerated mice: a comparison to those of nerve growth factor and neurotrophin-3. Neurosci Res 31, 227-234.
52. Kernie, S.G., Liebl, D.J. & Parada, L.F. (2000) BDNF regulates eating behavior and locomotor activity in mice. EMBO J 19, 1290-1300.
53. Khoshbouei, H., Sen, N., Guptaroy, B., Johnson, L., Lund, D., Gnegy, M.E., Galli, A. & Javitch, J.A. (2004) N-terminal phosphorylation of the dopamine transporter is required for amphetamine-induced efflux. PLoS Biol 2, 0387-0393.
54. Kluger, A., Gianutsos, J.G., Golomb, J., Ferris, S.H. & Reisberg, B. (1997) Motor/psychomotor dysfunction in normal aging, mild cognitive decline, and early Alzheimer's disease: diagnostic and differential diagnostic features. Int Psychogeriatr 9 (Suppl. 1), 307-316; discussion 317-321.
55. Kokmen, E., Bossemeyer, R.W. Jr, Barney, J. & Williams, W.J. (1977) Neurological manifestations of aging. J Gerontol 32, 411-419.
56. Kondo, M., Gray, L.J., Pelka, G.J., Christodoulou, J., Tam, P.P. & Hannan, A.J. (2008) Environmental enrichment ameliorates a motor coordination deficit in a mouse model of Rett syndrome - Mecp2 gene dosage effects and BDNF expression. Eur J Neurosci 27, 3342-3350.
57. Krantz, D.E., Peter, D., Liu, Y. & Edwards, R.H. (1997) Phosphorylation of a vesicular monoamine transporter by casein kinase II. J Biol Chem 272, 6752-6759.
58. Lee, E.W., Wei, L.J. & Amato, D. (1992) Cox-type regression analysis for large number of small groups of correlated failure time observations. Survival Analysis, State of the Art. Kluwer, Netherlands, pp. 237-247.
59. Liebl, D.J., Tessarollo, L., Palko, M.E. & Parada, L.F. (1997) Absence of sensory neurons before target innervation in brain-derived neurotrophic factor-, neurotrophin 3-, and TrkC-deficient embryonic mice. J Neurosci 17, 9113-9121.
60. Liu, X., Ernfors, P., Wu, H. & Jaenisch, R. (1995) Sensory but not motor neuron deficits in mice lacking NT4 and BDNF. Nature 375, 238-241.
61. Luellen, B.A., Bianco, L.E., Schneider, L.M. & Andrews, A.M. (2007) Reduced brain-derived neurotrophic factor is associated with a loss of serotonergic innervation in the hippocampus of aging mice. Genes Brain Behav 6, 482-490.
62. Lyons, W.E., Mamounas, L.A., Ricaurte, G.A., Coppola, V., Reid, S.W., Bora, S.H., Wihler, C., Koliatsos, V.E. & Tessarollo, L. (1999) Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proc Natl Acad Sci U S A 96, 15239-15244.
63. MacQueen, G.M., Ramakrishnan, K., Croll, S.D., Siuciak, J.A., Yu, G., Young, L.T. & Fahnestock, M. (2001) Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression. Behav Neurosci 115, 1145-1153.
64. Monteggia, L.M., Barrot, M., Powell, C.M., Berton, O., Galanis, V., Gemelli, T., Meuth, S., Nagy, A., Greene, R.W. & Nestler, E.J. (2004) Essential role of brain-derived neurotrophic factor in adult hippocampal function. Proc Natl Acad Sci U S A 101, 10827-10832.
65. Moron, J.A., Brockington, A., Wise, R.A., Rocha, B.A. & Hope, B.T. (2002) Dopamine uptake through the norepinephrine transporter in brain regions with low levels of the dopamine transporter: evidence from knock-out mouse lines. J Neurosci 22, 389-395.
66. Murer, M.G., Yan, Q. & Raisman-Vozari, R. (2001) Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Prog Neurobiol 63, 71-124.
67. Nagatsu, T. & Sawada, M. (2007) Biochemistry of postmortem brains in Parkinson's disease: historical overview and future prospects. J Neural Transm Suppl 72, 113-120.
68. Newman, R.P., LeWitt, P.A., Jaffe, M., Calne, D.B. & Larsen, T.A. (1985) Motor function in the normal aging population: treatment with levodopa. Neurology 35, 571-573.
69. Ossowska, K., Wolfarth, S., Schulze, G., Wardas, J., Pietraszek, M., Lorenc-Koci, E., Smialowska, M. & Coper, H. (2001) Decline in motor functions in aging is related to the loss of NMDA receptors. Brain Res 907, 71-83.
70. Richards, M., Bell, K., Dooneief, G., Marder, K., Sano, M., Mayeux, R. & Stern, Y. (1993) Patterns of neuropsychological performance in Alzheimer's disease patients with and without extrapyramidal signs. Neurology 43, 1708-1711.
71. Rozas, G., Guerra, M.J. & Labandeira-Garcia, J.L. (1997) An automated rotarod method for quantitative drug-free evaluation of overall motor deficits in rat models of parkinsonism. Brain Res Brain Res Protoc 2, 75-84.
72. Rustay, N.R., Wahlsten, D. & Crabbe, J.C. (2003) Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav Brain Res 141, 237-249.
73. Samuvel, D.J., Jayanthi, L.D., Bhat, N.R. & Ramamoorthy, S. (2005) A role for p38 mitogen-activated protein kinase in the regulation of the serotonin transporter: evidence for distinct cellular mechanisms involved in transporter surface expression. J Neurosci 25, 29-41.
74. Sandoval, V., Riddle, E.L., Hanson, G.R. & Fleckenstein, A.E. (2002) Methylphenidate redistributes vesicular monoamine transporter-2: role of dopamine receptors. J Neurosci 22, 8705-8710.
75. Saylor, A.J., Meredith, G.E., Vercillo, M.S., Zahm, D.S. & McGinty, J.F. (2006) BDNF heterozygous mice demonstrate age-related changes in striatal and nigral gene expression. Exp Neurol 199, 362-372.
76. Silhol, M., Bonnichon, V., Rage, F. & Tapia-Arancibia, L. (2005) Age-related changes in brain-derived neurotrophic factor and tyrosine kinase receptor isoforms in the hippocampus and hypothalamus in male rats. Neuroscience 132, 613-624.
77. Strand, A.D., Baquet, Z.C., Aragaki, A.K., Holmans, P., Yang, L., Cleren, C., Beal, M.F., Jones, L., Kooperberg, C., Olson, J.M. & Jones, K.R. (2007) Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration. J Neurosci 27, 11758-11768.
78. Volkow, N.D., Gur, R.C., Wang, G.J., Fowler, J.S., Moberg, P.J., Ding, Y.S., Hitzemann, R., Smith, G. & Logan, J. (1998) Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. Am J Psychiatry 155, 344-349.
79. Watanabe, H., Ohta, H., Imamura, L., Asakura, W., Matoba, Y. & Matsumoto, K. (1991) Effect of Panax ginseng on age-related changes in the spontaneous motor activity and dopaminergic nervous system in the rat. Jpn J Pharmacol 55, 51-56.
80. Yurek, D.M. & Fletcher-Turner, A. (2000) Lesion-induced increase of BDNF is greater in the striatum of young versus old rat brain. Exp Neurol 161, 392-396.
81. Yurek, D.M. & Fletcher-Turner, A. (2001) Differential expression of GDNF, BDNF, and NT-3 in the aging nigrostriatal system following a neurotoxic lesion. Brain Res 891, 228-235.